| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $34.6M | -2.1% | -4.7% |
| Cost of Revenue | $8.7M | -0.7% | -6.4% |
| Gross Profit | $25.9M | -2.5% | -4.2% |
| R&D Expense | $8.2M | -4.3% | -11.2% |
| SG&A Expense | $9.3M | -3.3% | -20.3% |
| Operating Income | -$8.0M | +12.9% | +40.1% |
| Pre-tax Income | -$6.4M | +10.4% | +43.3% |
| Income Tax | $16K | -90.9% | -91.3% |
| Net Income | -$6.4M | +12.4% | +44.1% |
| EPS (Basic) | -$0.15 | +11.8% | +44.4% |
| EPS (Diluted) | -$0.15 | +11.8% | +44.4% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $47.2M | +25.2% | +328.8% |
| Accounts Receivable | $14.8M | -19.0% | -37.6% |
| Current Assets | $206.0M | -4.1% | -10.7% |
| Total Assets | $224.8M | -4.4% | -10.4% |
| Current Liabilities | $77.1M | -6.1% | -8.2% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $8.5M | — | — |
| Capital Expenditures | $2.3M | — | — |
| Investing Cash Flow | $38.5M | — | — |
| Financing Cash Flow | -$14.9M | — | — |
| Free Cash Flow | $6.2M | — | — |
| $80.5M |
| -5.4% |
| -6.5% |
| Stockholders' Equity | $144.3M | -3.8% | -12.5% |